0000000000609077

AUTHOR

Jörg J. Vehreschild

showing 3 related works from this author

Posaconazole concentrations in the central nervous system

2008

more susceptible to the killing activity of caspofungin. This study is the first comparing caspofungin killing activity against the closely related species C. parapsilosis, C. orthopsilosis and C. metapsilosis. Killing curves, regardless of the medium used, showed a decreasing order of susceptibility to caspofungin: C. metapsilosis . C. orthopsilosis . C. parapsilosis. Based on high echinocandin MICs for C. parapsilosis sensu stricto, in the case of isolates identified as C. parapsilosis sensu lato low MICs of echinocandins may be regarded as an indicator that an isolate is in fact C. orthopsilosis or C. metapsilosis; in the case of isolates with low echinocandin MICs, DNA-based identificat…

PharmacologyMicrobiology (medical)PosaconazoleEchinocandinBiologyPharmacologybacterial infections and mycosesBiological fluidMicrobiologychemistry.chemical_compoundInfectious Diseaseschemistryparasitic diseasespolycyclic compoundsTriazole derivativesmedicinePharmacology (medical)CaspofunginEchinocandinsSensu strictoSerum chemistrymedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmo…

2018

ABSTRACT In patients with hematological malignancies, bronchoalveolar lavage fluid (BALF) specimens are commonly used for the diagnosis of mold infections. However, it is not clear whether the cell pellet (P) or the supernatant fraction (S) of the BALF specimen is optimal for molecular diagnostic testing. Thus, 99 BALF specimens were collected from 96 hematology patients with or without allogeneic hematopoietic stem cell transplant. The cell pellets and supernatants were processed alone and in combination (S/P) for testing by two fungus-specific real-time PCR assays compliant with international recommendations. The results achieved with S/P were revealed to be superior in comparison to thos…

Adult0301 basic medicineMicrobiology (medical)Mucoralesmedicine.medical_specialty030106 microbiologyMedizinMycologyReal-Time Polymerase Chain ReactionSensitivity and SpecificityGastroenterologylaw.inventionYoung Adult03 medical and health scienceslawInternal medicinemedicineHumansDNA FungalPolymerase chain reactionAgedAged 80 and overInvasive Pulmonary AspergillosisAspergillusHematologymedicine.diagnostic_testbiologyMolecular Diagnostic Testingbusiness.industryCancerMiddle Agedbiology.organism_classificationmedicine.diseaseFungal diseaseAspergillusBronchoalveolar lavageMolecular Diagnostic TechniquesMucoralesbusinessBronchoalveolar Lavage FluidInvasive Fungal Infections
researchProduct

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry

2009

Patients surviving invasive fungal disease (IFD) and needing further antineoplastic chemotherapy are at high risk of recurrent fungal infection. In the absence of randomised controlled trials in this area, secondary prophylactic regimens are diverse. From 448 patients registered with the Multinational Case Registry of Secondary Antifungal Prophylaxis, we performed an analysis of patients receiving caspofungin (CAS) or itraconazole (ITC). All patients had an underlying haematological malignancy and had been diagnosed with an episode of IFD earlier in their course of treatment. Data collected comprised demographics, underlying disease, first episode of IFD, antifungal prophylaxis, incidence a…

AdultMaleMicrobiology (medical)medicine.medical_specialtyAntifungal AgentsAdolescentItraconazoleAspergillosisChemopreventionEchinocandinsLipopeptidesYoung Adultchemistry.chemical_compoundCaspofunginInternal medicinemedicineHumansAspergillosisPharmacology (medical)RegistriesMycosisAgedFirst episodebusiness.industryIncidence (epidemiology)Stem cell transplantationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryTransplantationTreatment OutcomeInfectious DiseasesMycoseschemistryHematologic NeoplasmsChemoprophylaxisFemaleAntifungal prophylaxisItraconazoleCaspofunginbusinessmedicine.drugInternational Journal of Antimicrobial Agents
researchProduct